Content area

Abstract

CD4+ T cell differentiation requires metabolic reprogramming to fulfil the bioenergetic demands of proliferation and effector function, and enforce specific transcriptional programmes1-3. Mitochondrial membrane dynamics sustains mitochondrial processes4, including respiration and tricarboxylic acid (TCA) cycle metabolism5, but whether mitochondrial membrane remodelling orchestrates CD4+ T cell differentiation remains unclear. Here we show that unlike other CD4+ T cell subsets, T helper 17 (TH17) cells have fused mitochondria with tight cristae. T cell-specific deletion of optic atrophy 1 (OPA1), which regulates inner mitochondrial membrane fusion and cristae morphology6, revealed that TH17 cells require OPA1 for its control of the TCA cycle, rather than respiration. OPA1 deletion amplifies glutamine oxidation, leading to impaired NADH/NAD+ balance and accumulation of TCA cycle metabolites and 2-hydroxyglutarate-a metabolite that influences the epigenetic landscape5,7. Our multi-omics approach revealed that the serine/threonine kinase liver-associated kinase B1 (LKB1) couples mitochondrial function to cytokine expression in TH17 cells by regulating TCA cycle metabolism and transcriptional remodelling. Mitochondrial membrane disruption activates LKB1, which restrains 1L-17 expression. LKB1 deletion restores 1L-17 expression in TH17 cells with disrupted mitochondrial membranes, rectifying aberrant TCA cycle glutamine flux, balancing NADH/NAD+ and preventing 2-hydroxyglutarate production from the promiscuous activity of the serine biosynthesis enzyme phosphoglycerate dehydrogenase (PHGDH). These findings identify OPA1 as a major determinant of TH17 cell function, and uncover LKB1 as a sensor linking mitochondrial cues to effector programmes in TH17 cells.

Details

Title
An LKB1–mitochondria axis controls TH17 effector function
Author
Baixauli, Francesc 1 ; Piletic, Klara 2 ; Puleston, Daniel J 3 ; Villa, Matteo 4 ; Field, Cameron S 5 ; Flachsmann, Lea J; Quintana, Andrea; Rana, Nisha; Edwards-Hicks, Joy; Matsushita, Mai; Stanczak, Michal A; Grzes, Katarzyna M; Kabat, Agnieszka M; Fabri, Mario; Caputa, George; Kelly, Beth; Corrado, Mauro; Musa, Yaarub; Duda, Katarzyna J; Mittler, Gerhard; O'Sullivan, David; Sesaki, Hiromi; Jenuwein, Thomas; Buescher, Joerg M; Pearce, Edward J; Sanin, David E; Pearce, Erika L

 Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany 
 University of Cologne, Department of Dermatology, Cologne, Germany 
 Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA 
 Department of Oncology, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA 
 Department Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA 
Pages
555-5,561A-561V
Section
Article
Publication year
2022
Publication date
Oct 20, 2022
Publisher
Nature Publishing Group
ISSN
00280836
e-ISSN
14764687
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2727011337
Copyright
Copyright Nature Publishing Group Oct 20, 2022